You just read:

Merck KGaA, Darmstadt, Germany, Strengthens Immuno-Oncology Portfolio through Expansion of F-star Collaboration including LAG-3/PD-L1 Bispecific Antibody

News provided by

Merck KGaA, Darmstadt, Germany

Jun 04, 2017, 07:15 ET